[ Price : $8.95]
Washington commentator Bob Steeves reviews new risk data on orlistat and contrasts its continuing OTC availability to teens with e...[ Price : $8.95]
Janssen files an NDA seeking approval for a fixed-dose therapy combining canagliflozin and immediate-release metformin to treat pa...[ Price : $8.95]
FDA says a higher occurrence of major adverse cardiovascular events was observed in patients using Pfizer's smoking cessation aid ...[ Price : $8.95]
FDA accepts for review a Takeda and H. Lundbeck NDA for Brintellix for treating major depressive disorder in adult patients.[ Price : $8.95]
FDA releases discussion points on managing drug teratogenic risk for a rescheduled meeting of the Drug Safety and Risk Management ...[ Price : $8.95]
CDER Office of New Drugs director John Jenkins says his staff are worried about the outcomes from the addition of late-cycle meeti...[ Price : $8.95]
FDA approves a Sucampo Pharmaceuticals supplemental NDA for Rescula 0.15% for lowering intraocular pressure in patients with open-...[ Price : $8.95]
FDA releases the FDA-483 containing 14 inspection observations issued after an April inspection at Celltex Therapeutics.